Sophie Alderman, a 27-year-old with a history of severe mental illness, died by suicide in August 2022 at Rochford Hospital in Essex while being monitored by the Oxevision system.

Overview Debates Related claims Topics Sources

Sixteen-year-old Elise Sebastian killed herself in 2021 at Essex Partnership University NHS Foundation Trust after hospital staff muted the Oxevision camera monitoring alarm system.

The proposed FY26 budget restructuring includes a $1 billion funding reduction affecting community mental health centers, suicide prevention, and substance use treatment programs.

The JAMA Network Open study found that people diagnosed with attention-deficit/hyperactivity disorder face a 89% to 90% higher rate of death by suicide compared to individuals without ADHD.

Researchers observed that co-existing mental health conditions like depression, along with emotional regulation and impulse control challenges, may contribute to elevated suicide rates among people with ADHD.

The UK Medicines and Healthcare products Regulatory Agency announced updated safety warnings for all 28 authorised antidepressants, introducing boxed warnings on suicidal thoughts and behaviours in patient information leaflets

The Commission on Human Medicines review into antidepressant safety was initiated after patients and families raised concerns regarding the communication of suicidal thoughts and persistent sexual dysfunction risks

The Medicines and Healthcare products Regulatory Agency advised healthcare professionals to discuss suicidal risks when starting antidepressants, changing dosages, or conducting routine reviews

Medicines and Healthcare products Regulatory Agency chief safety officer Dr. Alison Cave urged patients not to stop taking antidepressants without first consulting their healthcare professional

The UK Medicines and Healthcare products Regulatory Agency expects all future licensed antidepressants to incorporate updated safety warnings on suicidal thoughts and sexual dysfunction to ensure consistent communication across healthcare settings

The Medicines and Healthcare products Regulatory Agency chief safety officer Dr. Alison Cave stated that antidepressant benefits outweigh risks for the vast majority of patients under clinical supervision

In January 2025, the senior coroner for Gloucestershire issued a prevention of future deaths report following the inquest into the death of Thomas Kingston

The senior coroner for Gloucestershire who investigated Thomas Kingston's death questioned whether risk communication regarding suicide and guidance on switching SSRI medications was adequate when patients experience no benefit or suffer adverse effects

Thomas Kingston took his own life while suffering from adverse effects of recently prescribed SSRI medications sertraline and citalopram

Canada should exclude mental illness as a sole condition for medically assisted dying

Outro plans to use its $7 million in capital to expand its network of deprescribing clinicians and develop artificial intelligence clinical decision support tools.

Approximately one in six Americans take an antidepressant medication, and average duration of use has surpassed five years.

Outro's deprescribing platform incorporates personalized hyperbolic tapering plans, compounded medication doses, patient monitoring, and specially-trained clinicians.

Outro plans to expand its tapering model into additional medication classes beyond antidepressants, including benzodiazepines, gabapentinoids, and GLP-1s.

Research led by Dr. Mark Horowitz found that four in five long-term antidepressant users were unable to stop taking their medications due to withdrawal symptoms.

Hyperbolic tapering is the most effective protocol for discontinuing psychiatric medications